Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,547,078
-$719,137 QoQ
Shares Held
17,904
-16.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.09%
of 13F equity value
Holder Rank
#1,689
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 81%
Shared 0%
None 19%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHELSEA COUNSEL CO holds $9,679,558 across 10 Drug Manufacturers - General names. JNJ ranks #1 (47.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
17,904 | $4,547,078 | |
| 2 | AMGN |
Amgen Inc
|
8,954 | $3,242,422 | |
| 3 | GSK |
GSK plc
|
9,360 | $490,651 | |
| 4 | PFE |
Pfizer Inc
|
20,000 | $481,600 | |
| 5 | LLY |
ELI LILLY & Co
|
351 | $420,999 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,840 | $364,940 | |
| 7 | SNY |
Sanofi
|
1,845 | $78,707 | |
| 8 | ABBV |
AbbVie Inc.
|
114 | $28,686 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,547,078 | 17,904 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $5,266,215 | 21,544 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $4,458,530 | 21,544 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $4,016,197 | 21,660 | Shares | Sole | 2025-11-25 | |
| 2025-06-30 | $3,308,565 | 21,660 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $3,628,579 | 21,880 | Shares | Sole | 2025-05-22 | |
| 2024-12-31 | $3,164,285 | 21,880 | Shares | Sole | 2025-02-27 | |
| 2024-09-30 | $3,828,505 | 23,624 | Shares | Sole | 2024-11-21 | |
| 2024-06-30 | $3,607,959 | 24,685 | Shares | Sole | 2024-11-21 | |
| 2024-03-31 | $3,946,524 | 24,948 | Shares | Sole | 2024-06-17 | |
| 2023-12-31 | $4,193,421 | 26,754 | Shares | Sole | 2024-02-21 | |
| 2023-09-30 | $4,418,783 | 28,371 | Shares | Sole | 2023-11-22 | |
| 2023-06-30 | $6,399,996 | 38,666 | Shares | Sole | 2023-11-22 | |
| 2023-03-31 | $6,032,290 | 38,918 | Shares | Sole | 2023-05-19 | |
| 2022-12-31 | $6,963,189 | 39,418 | Shares | Sole | 2023-02-23 | |
| 2022-09-30 | $6,741,540 | 41,268 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $7,970,731 | 44,903 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $8,047,659 | 45,408 | Shares | Sole | 2022-05-24 | |
| 2021-12-31 | $7,826,623 | 45,751 | Shares | Sole | 2022-05-23 | |
| 2021-09-30 | $7,429,968 | 46,006 | Shares | Sole | 2022-02-10 | |
| 2021-06-30 | $7,457,120 | 45,266 | Shares | Sole | 2022-02-10 | |
| 2021-03-31 | $7,027,770 | 42,761 | Shares | Sole | 2022-02-10 | |
| 2020-12-31 | $6,759,470 | 42,950 | Shares | Sole | 2022-03-08 | |
| 2020-09-30 | $6,583,175 | 44,218 | Shares | Sole | 2022-05-06 | |
| 2020-06-30 | $6,470,807 | 46,013 | Shares | Sole | 2022-05-06 | |
| 2020-03-31 | $5,886,818 | 44,893 | Shares | Sole | 2020-06-12 | |
| No filing history on record for this holder in this stock. | ||||||